UMC IDMP Request and Publish API
1.0.0 - CI Build International flag

UMC IDMP Request and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions

Example AdministrableProductDefinition: AdministrableProductDefinition level 3

Profile: http://umcterminologies.org/StructureDefinition/AdministrableProductDefinition-pub

Pharmaceutical dose form - BasicDoseForm: standardterms.edqm.eu: 0069 (Tablet)

Pharmaceutical dose form - ReleaseCharacteristics: standardterms.edqm.eu: 0047 (Conventional)

Pharmaceutical dose form - AdministrationMethod: standardterms.edqm.eu: 0019 (Swallowing)

Pharmaceutical dose form - IntendedSite: standardterms.edqm.eu: 0031 (Oral)

Parent PhPID: https://umcterminologies.org/idmp/AdministrableProductDefinition/UTPHPID2C4FBA65KDM1P6

identifier: Level 3/UTPHPID5F4A1M772SP14T

status: Active

RouteOfAdministrations

-Code
*

Generated Narrative: Ingredient #UTGSID44RS1U925RP22

Profile: http://umcterminologies.org/StructureDefinition/Ingredient-pub

status: Active

for: AdministrableProductDefinition: extension = Tablet (standardterms.edqm.eu#0069),Conventional (standardterms.edqm.eu#0047),Swallowing (standardterms.edqm.eu#0019),Oral (standardterms.edqm.eu#0031),->https://umcterminologies.org/idmp/AdministrableProductDefinition/UTPHPID2C4FBA65KDM1P6; identifier = Level 3; status = active

role: Active

substance

Codes

-Reference
*Nilotinib tartrate